HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): S. Geroulanos Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dimopoulou, I. Articles by Cokkinos, D. V. Search for Related Content PubMed PubMed Citation Articles by Dimopoulou, I. Articles by Cokkinos, D. V.

J Thorac Cardiovasc Surg 1997;114:31-37
© 1997 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

LOW-DOSE AMIODARONE-RELATED COMPLICATIONS AFTER CARDIAC OPERATIONS

Received for publication May 9, 1996 revisions requested June 18, 1996; revisions received Nov. 25, 1996 accepted for publication Dec. 23, 1996. Address for reprints: D. V. Cokkinos, MD, First Department of Cardiology, Onassis Cardiac Surgery Center, 356, Sygrou Ave., 176 74 Athens, Greece.

Abstract

Objective: High-dose preoperative amiodarone therapy has been implicated as a risk factor for serious complications after cardiac operations. To investigate the effect of preoperative low-dose amiodarone treatment on early postoperative outcome after cardiac operations, we prospectively studied 88 patients.Methods: Forty-four patients were receiving amiodarone (mean daily dose ± standard deviation, 205 ± 70 mg/day) and 44 patients were controls matched in pairs. The following parameters were recorded after the operation in all patients: (1) the ratio of oxygen tension to inspired oxygen fraction on arrival in the intensive care unit and 2, 4, 6, 10, 14, 18, and 22 hours thereafter; (2) the occurrence of acute respiratory distress syndrome; (3) early postoperative cardiac complications; and (4) the type and number of inotropic agents or vasopressors (or both) needed.Results: No difference in the ratio of oxygen tension to inspired oxygen fraction was noted at the various time intervals between amiodarone-treated patients and control patients. Overall, only one patient had acute respiratory distress syndrome in the amiodarone group, but he had multiple other factors known to predispose to acute lung injury. Several cardiac complications, such as pulmonary edema, temporary pacing, and need for intraaortic balloon pump counterpulsation, were observed more frequently in amiodarone-treated patients than in control patients. In addition, amiodarone-treated patients required more frequent inotropic support (73% vs 43%, p = 0.003) and more inotropic drugs or vasopressors (or both) per patient than did control patients (1.4 ± 1.1 vs 0.6 ± 0.8, p = 0.002).Conclusion: Preoperative low-dose amiodarone therapy does not seem to be related to significant postoperative lung toxicity, but it is associated with various cardiac complications and an increased need for more intense inotropic support after cardiac operations. These findings may be related to the drug's depressant effect on the myocardium

This article has been cited by other articles:

				E. Crystal, S. Kahn, R. Roberts, K. Thorpe, M. Gent, J. A. Cairns, P. Dorian, and S. J. Connolly Long-term amiodarone therapy and the risk of complications after cardiac surgery: Results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT) J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 633 - 637. [Abstract] [Full Text] [PDF]

				M. C. Ott, A. Khoor, J. P. Leventhal, T. E. Paterick, and C. D. Burger Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone Chest, February 1, 2003; 123(2): 646 - 651. [Abstract] [Full Text] [PDF]

				H. Ashrafian and P. Davey Is Amiodarone an Underrecognized Cause of Acute Respiratory Failure in the ICU? Chest, July 1, 2001; 120(1): 275 - 282. [Abstract] [Full Text] [PDF]

				M. M. Treggiari-Venzi, J.-L. Waeber, T. V. Perneger, P. M. Suter, R. Adamec, and J.-A. Romand Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery Br. J. Anaesth., November 1, 2000; 85(5): 690 - 695. [Abstract] [Full Text] [PDF]

				C. W. Hogue Jr and M. L. Hyder Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment Ann. Thorac. Surg., January 1, 2000; 69(1): 300 - 306. [Abstract] [Full Text] [PDF]